Research programme: Nogo receptor decoy - Axerion Therapeutics/NCATS

Drug Profile

Research programme: Nogo receptor decoy - Axerion Therapeutics/NCATS

Alternative Names: NgR(310)ecto-Fc

Latest Information Update: 05 Aug 2016

Price : $50

At a glance

  • Originator Axerion Therapeutics
  • Developer Axerion Therapeutics; National Center for Advancing Translational Sciences
  • Class Proteins
  • Mechanism of Action Myelin protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Spinal cord injuries

Most Recent Events

  • 05 Aug 2016 Preclinical development is ongoing in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top